Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Works For Medicare: Partnership With Unions Will Help Part D Roll-Out

This article was originally published in The Pink Sheet Daily

Executive Summary

The Pharmaceutical Research & Manufacturers of America will work through a formal partnership with organized labor to promote the Medicare Part D benefit to retirees

You may also be interested in...



Medicare Rx "On Track And On Schedule," CMS' McClellan Says; "Non-Interference" Not An Issue

The Senate's rejection of legislation to allow HHS intervention in Medicare drug price negotiations reflects the Centers for Medicare & Medicaid Services' confidence that the new outpatient drug benefit will be working as planned on Jan. 1, CMS Administrator Mark McClellan said March 17

Medicare Rx "On Track And On Schedule," CMS' McClellan Says; "Non-Interference" Not An Issue

The Senate's rejection of legislation to allow HHS intervention in Medicare drug price negotiations reflects the Centers for Medicare & Medicaid Services' confidence that the new outpatient drug benefit will be working as planned on Jan. 1, CMS Administrator Mark McClellan said March 17

PhRMA Launching National Patient Assistance Clearinghouse April 5

The Partnership for Patient Assistance will launch a nationwide campaign to enroll uninsured patients in prescription drug support plans. The program will feature a website and call center modeled on “pilots” conducted in three states; it will direct patients to 275 different manufacturer, government or third-party supported programs.

Topics

UsernamePublicRestriction

Register

ID1132115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel